Open Access
Review Article

Table 2

Pooled prevalence of Cryptosporidium in HIV-positive patients and subgroup analyses.

Group Number of studies Pooled prevalence (CI 95%) Heterogeneity
p-value
p value I2 (%)
Diagnostic method p < 0.05
Staining 140 10.0% (8.4%–11.8%) <0.001 96.00
Antigen detection 19 26.3% (15.0%–42.0%) <0.001 96.90
Molecular 28 13.5% (8.9%–19.8%) <0.001 95.60
Country*         p < 0.05
 Brazil 12 5.4% (2.5%–11.6%) <0.001 93.90
 China 6 7.2% (3.5%–14.3%) <0.001 87.50
 Ethiopia 18 9.8% (6.5%–14.7%) <0.001 95.70
 India 41 14.1% (10.5%–18.7%) <0.001 95.90
 Iran 10 11.1% (6.0%–19.5%) <0.001 89.40
 Malaysia 7 9.1% (5.0%–15.8%) <0.001 86.60
 Nigeria 11 10.6% (3.9%–25.6%) <0.001 98.30
 Thailand 8 11.0% (6.2%–18.7%) <0.001 85.40
Region  p = 0.46
 African Region 53 11.9% (8.8%–16.0%) <0.001 97.00
 Eastern Mediterranean Region 10 11.1% (6.0%–19.5%) <0.001 89.40
 European Region 5 5.4% (1.0%–23.7%) <0.001 92.00
 Region of the Americas 23 9.8% (6.4%–14.8%) <0.001 97.30
 South-East Asia Region 53 12.7% (9.7%–16.4%) <0.001 95.50
 Western Pacific Region 17 7.7% (4.7%–12.3%) <0.001 92.60
Income Level         p = 0.43
 High income 8 4.1% (2.4%–6.9%) <0.001 77.80
 Upper-middle income 52 10.4% (8.0%–13.5%) <0.001 94.10
 Lower-middle income 68 13.1% (10.2%–16.6%) <0.001 96.30
 Low income 33 10.9% (7.6%–15.2%) <0.001 96.30
Number of Participants         p < 0.05
 <100 66 15.4% (11.8%–19.8%) <0.001 91.00
 >100 95 8.9% (7.2%–11.0%) <0.001 97.30
*

Only countries with more than 5 included studies are shown.

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.